JN Medical

JN International Medical Corporation (JNI) is a biopharmaceutical company based in Omaha, Nebraska, specializing in the development and manufacture of affordable vaccines and diagnostic tools for infectious diseases. The company primarily targets global health challenges in developing nations, focusing on providing high-quality, low-cost medical solutions. Its lead product, Menovax, is a quadrivalent meningococcal vaccine that addresses serogroups A, C, Y, and W-135. JNI also maintains a pipeline of vaccine candidates for cholera and typhoid, alongside a suite of rapid diagnostic tests for tuberculosis and HIV. The company operates with a mission to bridge the gap in healthcare accessibility through innovative vaccine conjugation and diagnostic technologies.